Abstract
As the first country to recognize AIDS, the United States was inevitably the first to develop and implement measures to reduce the transmission of the disease by blood transfusion. In essence, the problem has been attacked at three levels; first by the selection of low risk donor populations; secondly by use of laboratory test procedures and finally, by inactivating viruses in products derived from pooled plasma. The sensitive social issues associated with AIDS, along with the uniform fatality of the disease, generated numerous ethical, social and medical problems which had to be resolved during the development of the screening programmes. At the same time, laboratory tests for the identification of potentially infectious donors were developed, commercialized and implemented in a remarkably short time span. In fact, within two years of the initial recognition of the AIDS virus, donor testing was uniformly in place. It is reasonable to claim that these activities have prevented a significant number of cases of transfusion associated AIDS cases, as testing alone has identified several thousand infected and potentially infectious donors during its first year. Major milestones in the management of transfusion AIDS in the United States are outlined in Table 8.1. Even so, it must be remembered that only 2% of AIDS cases in the United States are due to transfusion and the major problems of this epidemic are yet to be solved.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alter, H. J., Esteban, J. I., Shih, J. W-K., Kay, J. and Tai, C. C. (1985) A prospective study of the infectivity of anti-HTLV III positive blood donors (abstract). Transfusion, 25, 479.
Amman, A. J., Cowan, M. J., Wara, D. W. and Weintrub, P. (1983) Acquired immunodeficiency in an infant: Possible transmission by means of blood transfusion. Lancet, i, 956.
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T. et al. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 220, 868.
Brown, F. (1986) Human immunodeficiency virus (Letter). Science, 232, 1486.
Burke, D.S. and Redfield, R. R. (1986) False-positive Western blot tests for antibodies to HTLV III. JAMA, 256, 347.
CDC (1981a) Pneumocystis pneumonia-Los Angeles. MMWR, 30, 250.
CDC (1981b) Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men — New York City and California. MMWR, 30, 305.
CDC (1982a) Pneumocystis carinii pneumonia among persons with hemophilia A. MMWR, 31, 365.
CDC (1982b) Possible transfusion-associated acquired immune deficiency syndrome (AIDS) — California. MMWR, 31, 652–4.
CDC (1983) Prevention of acquired immune deficiency syndrome (AIDS): Report of interagency recommendations. MMWR, 32, 101.
CDC (1985a) Provisional public health service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR, 34, 1.
CDC (1985b) Update: Revised Public Health Service definition of persons who should refrain from donating blood and plasma — United States. MMWR, 34, 547.
CDC (1986a) Transfusion-associated human T-lymphotropic virus type III/Lymphadenopathy-associated virus infection from a seronegative donor — Colorado. MMWR, 35, 389.
CDC (1986b) Human T-lymphotropic virus type III lymphadenopathy-associated virus antibody testing at alternate sites. MMWR, 35, 284–7.
Curran, J. W., Lawrence, D. N., Jaffe, H., Kaplan, J. E. et al. (1984) Acquired immunodeficiency syndrome (AIDS) associated with transfusion. N. Engl. J. Med., 310, 69.
Dahlke, M. B. (1984) Designated blood donations. N. Engl. J. Med., 310, 1194.
Fang, C. T., Darr, F., Kleinman, S., Wehling, R. H. and Dodd, R. Y. (1986) Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotropic virus, type HI, and their relationship to Western blotting. Transfusion, 26, 208.
Forstein, M., Page, P., Coburn, R., Corwell, R. C. et al. (1985) Alternative sites for screening blood for antibodies to AIDS virus. N. Engl. J. Med., 313, 1158.
Gallo, R. C., Salahuddin, S. Z., Popovic, M., Shearer, G. M. et al. (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV HI) from patients with AIDS and at risk for AIDS. Science, 224, 500.
Holland, P. V., Richards, C. A., Teghtmeyer, J. R., Douville, C. M., Carson, J. R., Hinrichs, S. H. and Pederson, N. C. (1985) Anti-HTLVIII testing of blood donors: Reproducibility and confirmability of commercial test kits. Transfusion, 25, 395–7.
Kalish, R. I., Cable, R. G. and Roberts, S. C. (1986) Voluntary deferral of blood donations and HTLV HI antibody positives. N. Engl. J. Med., 314, 115.
Kleinman, S., Thompson, P. and Kaplan, H. (1984) Evaluation of donor screening procedures for AIDS prevention in a high risk area (abstract). Transfusion, 24, 434.
Kuhnl, P. S., Seidl, S. and Holzberger, G. (1985) HLA-DR4 antibodies cause positive HTLV antibody ELISA results. Lancet, i, 222.
Kuritsky, J. N., Rastogi, S. C., Faich, G. A., Schorr, J. B. et al. (1986) Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotropic III virus, type III. Transfusion, 26, 205.
Levy, J. A., Hoffman, A. D., Kramer, S. M., Landis, J. A. et al. (1984) Isolation of lymphocytopathic retrovirus from San Francisco patients with AIDS. Science, 225, 840.
Lui, K.-J., Lawrence, D. N., Morgan, W. M., Peterman, T. A. et al. (1986) A model-based approach for estimating the mean incubation period of transfusion associated acquired immunodeficiency syndrome. Proc. Natl Acad. Sci. USA, 83, 3051.
Mason, J. O. (1985) Alternative sites for screening blood for antibodies to AIDS virus. N. Engl. J. Med., 313, 1157–8.
Mayer, K. H., Stoddard, A. M., McCusker, J., Ayotte, D. et al. (1986) Human T-lymphotropic virus type III in high risk, antibody negative homosexual men. Ann. Intern. Med., 104, 194.
Osterholm, M. T., Bowman, R. J., Chopek, M. W., McCullough, J., Korlath, J. and Polesky, H. (1985) Screening donated blood and plasma for HTLV III antibody. N. Engl. J. Med., 312, 1185–9.
Peterman, T. A., Jaffe, H. W. and Feorino, P. M. (1985) Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA, 254, 2913.
Pindyck, J., Waldmann, A., Zang, E., Oleszko, W. et al. (1985) Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion: Evidence of volunteer blood donor cooperation. Transfusion, 25, 3.
Popovic, M., Sarngadharan, M. G., Read, E. and Gallo, R. C. (1984) Detection, isolation and continuous production of cytopathic retroviruses (HTLV III) from patients with AIDS and pre-AIDS. Science, 224, 497.
Sarngadharan, M. G., Popovic, M., Bruch, L., Schupbach, J. and Gallo, R. C. (1984) Antibodies reactive with human T-lymphotropic retroviruses (HTLV III) in the serum of patients with AIDS. Science, 224, 506.
Sayers, M. H., Beatty, P. G. and Hansen, J. A. (1986) HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III. Transfusion, 26, 113.
Schorr, J. B., Berkowitz, A., Cumming, P. D., Katz, A. J. and Sandler, S. G. (1985) Prevalance of HTLV III antibody in American blood donors. N. Engl. J. Med., 313, 384.
Ward, J. W., Grindon, A. J., Feorino, P. M., Schable, C., Parvin, M. and Allen, J. R. (1986) Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV III. JAMA, 256, 357–61.
Williams, A. E., Luban, N. L. C., Fang, C. T. and Dodd, R. Y. (1985) Serial development of anti-HTLV HI and AIDS-related complex in highly transfused children (Abstract). Transfusion, 25, 479.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Dodd, R.Y. (1987). Donor screening for HIV in the United States. In: Madhok, R., Forbes, C.D., Evatt, B.L. (eds) Blood, Blood Products — and AIDS —. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3394-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4899-3394-2_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-8018-3608-4
Online ISBN: 978-1-4899-3394-2
eBook Packages: Springer Book Archive